What is Pancreatic Polypeptide?
A 36-amino-acid pancreatic hormone in the same family as peptide YY and neuropeptide Y.
Pancreatic Polypeptide in the library · · Human Trials · What are peptides?
5 registered trials · 194 indexed papers · 397 human / 127 animal studies
From the PeptideWhiz library entry. "As described" sections summarize claims made in the sources; they are not PeptideWhiz endorsements.
What it is
A 36-amino-acid pancreatic hormone in the same family as peptide YY and neuropeptide Y.
Type: Peptide hormone.
Definition (National Library of Medicine)
“A 36-amino acid pancreatic hormone that is secreted mainly by endocrine cells found at the periphery of the islets of langerhans and adjacent to cells containing somatostatin and glucagon. Pancreatic polypeptide (PP), when administered peripherally, can suppress gastric secretion, gastric emptying, pancreatic enzyme secretion, and appetite. A lack of pancreatic polypeptide (PP) has been associated with obesity in rats and mice.”
- MeSH: Pancreatic Polypeptide
Human research
The registered human trials and peer-reviewed human studies linked below are listed from ClinicalTrials.gov and PubMed. A study is linked only when Pancreatic Polypeptide is one of its interventions, or is named in the study title or subject headings.
Listing a study does not mean it showed a benefit, and it is not medical advice.
Registered human trials (5)
| Trial | Phase | Status | Year | Enrolled |
|---|---|---|---|---|
| Pancreatic Polypeptide as a Modulator of Amylin- Induced Satiety in Healthy Humans | recruiting | 2026 | 18 | |
| Safety, Tolerability and Efficacy Study of PP1420 in HV | Phase 1/Phase 2 | terminated | 2014 | 49 |
| A First-Time-in-Human Study to Assess the Safety and Tolerability of PP 1420 in Healthy Subjects | Phase 1 | completed | 2010 | 13 |
| Effect of Pancreatic Polypeptide on Gastric Motor Function and Food Intake in Humans | Phase 4 | completed | 2010 | 12 |
| The Effect of Pancreatic Polypeptide on Insulin Requirements for Type 1 & Post-pancreatectomy Diabetic Patients | Phase 2 | terminated | 2007 | 8 |
Peer-reviewed studies (194)
More cited research
- Human pancreatic polypeptide has a marked diurnal rhythm that is affected by ageing and is associated with the gastric TFF2 circadian rhythm (2006, human observational)
- In vitro release of vasoactive intestinal polypeptide and pancreatic polypeptide from human VIPoma cells and its inhibition by somatostatin analogue (SMS 201-99 (1994, human case report)
- Apomorphine-induced nausea in humans: release of vasopressin and pancreatic polypeptide (1988, human observational)
- Stimulation of human pancreatic polypeptide and gastrin by Boots and GIH secretin: in vitro and in vivo studies (1987, human observational)
- Pancreatic polypeptide controls energy homeostasis via Npy6r signaling in the suprachiasmatic nucleus in mice (2014, animal)
- Metastatic pancreatic polypeptide-secreting islet cell tumor in a dog (2010, animal)
- [Secretion of insulin and pancreatic polypeptide from the isolated perfused ventral and dorsal portions of the rat pancreas] (1992, animal)
- Pancreatic polypeptide secretion from the isolated perfused ventral and dorsal areas of the rat pancreas (1988, animal)
Conditions researched
- Delayed gastric emptying on GLP-1 medicines
- Dementia, Alzheimer's & cognitive decline
- Fat loss, obesity & body recomposition
- Gallbladder and gallstones
- Gut: IBD (Crohn's, colitis), leaky gut, IBS & ulcers
- Insulin resistance, prediabetes & type 2 diabetes
- Pancreatitis (after the acute phase)
- Post-surgical inflammation and surgery recovery
Related compounds
- Calcitonin
- Cholecystokinin (CCK)
- Exenatide
- Glucagon
- Liraglutide
- Octreotide
- Somatostatin
- Endothelin-1
- Insulin (regular human)
- L-Carnitine
FAQ
What is Pancreatic Polypeptide?
A 36-amino-acid pancreatic hormone in the same family as peptide YY and neuropeptide Y.
How many registered human trials study Pancreatic Polypeptide?
The PeptideWhiz trial index lists 5 registered trials for Pancreatic Polypeptide, the most recent from 2026.
How much published research exists on Pancreatic Polypeptide?
The PeptideWhiz paper index links 194 PubMed papers to Pancreatic Polypeptide; by study type, 397 human and 127 animal studies.
Which conditions is Pancreatic Polypeptide researched for?
Delayed gastric emptying on GLP-1 medicines, Dementia, Alzheimer's & cognitive decline, Fat loss, obesity & body recomposition, Gallbladder and gallstones, Gut: IBD (Crohn's, colitis), leaky gut, IBS & ulcers, Insulin resistance, prediabetes & type 2 diabetes, Pancreatitis (after the acute phase), Post-surgical inflammation and surgery recovery.
Research and education only. Not medical advice. No dosing guidance. Data: ClinicalTrials.gov registry and PubMed via the PeptideWhiz index (204,289 studies).